Menu
Browse all
Categories
Browse all
Categories
Home Intermediates, Fine and Specialty Chemicals Chiral Intermediates
Products (628) Suppliers (74)

Category

Chiral Intermediates

Editor's choice

news
UPDATED: COVID-19 Pharma Development Tracker
23 Nov 2020

UPDATED: COVID-19 Pharma Development Tracker
 
news
UPDATED: COVID-19 Pharma Development Tracker
23 Nov 2020

UPDATED: COVID-19 Pharma Development Tracker
news
CPhI & P-MEC China 2020 adapts to customer needs with hybrid pharma event
23 Nov 2020

CPhI & P-MEC China 2020 adapts to customer needs with hybrid pharma event
news
Indian authority extends comments deadline for API anti-dumping probe
19 Nov 2020

Indian authority extends comments deadline for API anti-dumping probe
news
European Commission wraps up CureVac COVID-19 vaccine supply deal
17 Nov 2020

European Commission wraps up CureVac COVID-19 vaccine supply deal

Content feed

Supplier brochure
Company Profile

Company Profile

Advanced Intermediates | Antibiotics | API Contract Manufacturing | Capsules | Chemical synthesis/analysis | Chiral Intermediates | Consumables | Contract Manufacturing | Creams, Lotions, Ointments | Custom Manufacturing (general category) | Custom Manufacturing of Dosage Form Drugs | Custom Manufacturing/Exclusive Synthesis of Fine Chemicals | Drops | Drug Formulation (general category) | Fine Chemicals (general category) | Formulation development | Functional Food And Nutraceutical Ingredients | Hormones & Synthetic Substances | Injectables | Marketing Services | Medical Devices | Other APIs | Other Generic APIs | Out-licensing | Parenterals | Pharmaceutical Technology (general category) | Plant Extracts | Powders | Regulated Fine Chemicals | Soft tabs | Specialty Chemicals | Suspensions | Syrups | Tablets | APIs (Active Pharmaceutical Ingredients) | Generic APIs | Intermediates, Fine and Specialty Chemicals | Finished Dosage Forms | Natural Extracts
news
Seqirus to build $800m influenza vaccine manufacturing facility in Australia

Seqirus to build $800m influenza vaccine manufacturing facility in Australia

Biomanufacturing | Biopharmaceuticals
news
Early trial results hail Moderna's COVID-19 vaccine as 94.5% effective

Early trial results hail Moderna's COVID-19 vaccine as 94.5% effective

Biopharmaceuticals
news
Vibalogics establishes US presence with virotherapy facility in Boston

Vibalogics establishes US presence with virotherapy facility in Boston

Contract Manufacturing | Biopharmaceuticals | Contract Services - Contract Services

Over 680,000 products from more than 7,300 suppliers

The most complete product and supplier search engine in the pharma industry

Register now

Upcoming events

16 dec 2020

CPhI & PMEC China 2020

SNIEC, Shanghai, China
27 jan 2021

CPhI & PMEC India 2020

India Expo Centre, Greater Noida, Delhi NCR
See all events

Top Selected Products

Scale-up and Demonstration

Enzymicals AG

Scale-up and Demonstration

Enzymical is your experienced partner in scaling up processes for enzyme production and/or application of enzyme technology. We are experienced in ...

More

Enzymaster (Ningbo) Bio-Engineering Co., Ltd

(R)-1-(1-Naphthyl)ethylamine

(R)-1-(1-Naphthyl)ethylamine is the intermediate of Cinacalcet

More

Hangzhou Bioking Biochemical Engineering Co Ltd

D(-)-Tartaric Acid

D(-)-Tartaric acid is a white, crystalline acid which is widely used as intermediate or resolving agent in pharmaceutical industry. 

More

Infinium Pharmachem Pvt. Ltd.

Lead Iodide

Infinium Pharmachem Manufacturing various Organic and Inorganic Iodine derivatives. Cas No :- 10101-63-0 Molecular Formula :- PbI2 Syn...

More

VIO CHEMICALS AG

(S)-2-Methylproline

VIO Chemicals offers steroid and other intermediates, including (S)-2-Methylproline to use as building block. CAS No: 42856-71-3

More
Show more products

Browse all categories